Israeli one-second Covid-19 test to be piloted in European airports

By October 02 2020, 13:08 Latest News No Comments

An Israeli self-service instant Covid-19 test is to be trialled at European airports in conjunction with ICTS Europe, a leading security provider at major airports worldwide.

In order to mitigate the risk of Covid-19 infection, ICTS Europe has partnered with Israeli AI software company Virusight – a collaboration between Newsight Imaging and Sheba Medical Centre – to incorporate the test into airport kiosks where passengers’ body temperatures are checked and travel documents scanned.

The test uses a simple oral mouth rinse and has been clinically proven to identify viruses including coronavirus by analysing light wavelengths in saliva. The SpectraLIT system is powered by unique machine-learning and artificial intelligence (AI) capabilities.

ICTS Europe’s President and CEO, Oren Sapir, said: “As travel restrictions are gradually lifted, innovation and technology will continue to be central to the industry’s recovery, and so we are proud and extremely pleased to join forces with Virusight to unveil SpectraLIT”.

He added: “Thanks to its flexibility, SpectraLIT can be tailored to meet the specific needs of each individual airport, airline or any other organisation who may be looking to integrate screening capabilities into its operations”.

Eli Assoolin, CEO of Newsight and Board Chairman at Virusight Diagnostic said: “We are very pleased to sign this important LOI with ICTS Europe, just a few weeks after we have formed our joint venture with Sheba Medical Center. Our solution for COVID-19 is currently in the process of receiving regulation approval and is ready for deployment in COVID-19 hot-spots such as airports”.

Dr. Eyal Zimlichman, Chief Medical Officer and Chief Innovation Officer at Sheba Medical Center stated: “This agreement, is an important milestone for the company, digital health will transform healthcare and this is yet another example of leveraging AI technology to mitigate COVID-19. We formed ARC, our innovation model with the aim to accelerate innovation through redesign healthcare by collaborating with partners. This is an active example of the model at work”.

Print Friendly, PDF & Email